Annual Total Liabilities
$18.28 M
-$20.74 M-53.16%
December 31, 2023
Summary
- As of February 8, 2025, PRAX annual total liabilities is $18.28 million, with the most recent change of -$20.74 million (-53.16%) on December 31, 2023.
- During the last 3 years, PRAX annual total liabilities has risen by +$2.56 million (+16.28%).
- PRAX annual total liabilities is now -56.41% below its all-time high of $41.94 million, reached on December 31, 2021.
Performance
PRAX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$33.59 M
+$11.63 M+52.94%
September 30, 2024
Summary
- As of February 8, 2025, PRAX quarterly total liabilities is $33.59 million, with the most recent change of +$11.63 million (+52.94%) on September 30, 2024.
- Over the past year, PRAX quarterly total liabilities has increased by +$12.86 million (+62.07%).
- PRAX quarterly total liabilities is now -30.72% below its all-time high of $48.48 million, reached on March 31, 2022.
Performance
PRAX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
PRAX Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -53.2% | +62.1% |
3 y3 years | +16.3% | -1.0% |
5 y5 years | +255.1% | -1.0% |
PRAX Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -56.4% | at low | -30.7% | +83.8% |
5 y | 5-year | -56.4% | +141.1% | -30.7% | +343.1% |
alltime | all time | -56.4% | +255.1% | -30.7% | +343.1% |
Praxis Precision Medicines Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $33.59 M(+52.9%) |
Jun 2024 | - | $21.96 M(+6.0%) |
Mar 2024 | - | $20.73 M(+13.4%) |
Dec 2023 | $18.28 M(-53.2%) | $18.28 M(-8.5%) |
Sep 2023 | - | $19.97 M(-28.4%) |
Jun 2023 | - | $27.87 M(-17.8%) |
Mar 2023 | - | $33.91 M(-13.1%) |
Dec 2022 | $39.02 M | $39.02 M(+22.9%) |
Sep 2022 | - | $31.74 M(-23.6%) |
Jun 2022 | - | $41.55 M(-14.3%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $48.48 M(+15.6%) |
Dec 2021 | $41.94 M(+166.8%) | $41.94 M(+47.2%) |
Sep 2021 | - | $28.49 M(+44.3%) |
Jun 2021 | - | $19.74 M(+43.7%) |
Mar 2021 | - | $13.74 M(-12.6%) |
Dec 2020 | $15.72 M(+107.4%) | $15.72 M(+48.6%) |
Sep 2020 | - | $10.58 M(+23.8%) |
Jun 2020 | - | $8.55 M(+12.7%) |
Dec 2019 | $7.58 M(+47.3%) | $7.58 M |
Dec 2018 | $5.15 M | - |
FAQ
- What is Praxis Precision Medicines annual total liabilities?
- What is the all time high annual total liabilities for Praxis Precision Medicines?
- What is Praxis Precision Medicines annual total liabilities year-on-year change?
- What is Praxis Precision Medicines quarterly total liabilities?
- What is the all time high quarterly total liabilities for Praxis Precision Medicines?
- What is Praxis Precision Medicines quarterly total liabilities year-on-year change?
What is Praxis Precision Medicines annual total liabilities?
The current annual total liabilities of PRAX is $18.28 M
What is the all time high annual total liabilities for Praxis Precision Medicines?
Praxis Precision Medicines all-time high annual total liabilities is $41.94 M
What is Praxis Precision Medicines annual total liabilities year-on-year change?
Over the past year, PRAX annual total liabilities has changed by -$20.74 M (-53.16%)
What is Praxis Precision Medicines quarterly total liabilities?
The current quarterly total liabilities of PRAX is $33.59 M
What is the all time high quarterly total liabilities for Praxis Precision Medicines?
Praxis Precision Medicines all-time high quarterly total liabilities is $48.48 M
What is Praxis Precision Medicines quarterly total liabilities year-on-year change?
Over the past year, PRAX quarterly total liabilities has changed by +$12.86 M (+62.07%)